A national survey of knowledge, attitude, practice, and barriers towards pharmacovigilance and adverse drug reaction reporting among hospital pharmacy practitioners in the United Arab Emirates

Table 7 Reporting departments (n = 177^a)

Reporting institution	Numbers	Frequency (%)
Ministry of Health (MOH)	59	17.3
Dubai Healthcare Authority (DHA)	42	12.3
Both MOH and DHA	27	7.9
Drug manufacturer	31	9.1
Physician	1	0.3
All of the above	2	0.6
Hospital management	6	1.8
Clinical pharmacist in hospital	2	0.6
Quality department	7	2

ISSN: 2052-3211